RxDoctor Payments DataLook up a doctor →

Christopher Lecroy, MD

Vascular Surgery · Pensacola, FLNPI 1821204983

Payments from drug & device makers

$173,161in general payments, 2019–2025

Across 488 payments — averaging $354.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Veryan Medical Incorporated$129K
  • Bolton Medical Inc$21K
  • Endologix LLC$5K
  • GE HealthCare$4K
  • Medtronic$4K
  • W. L. Gore & Associates, Inc.$3K
  • plus $7K from 28 others
$52,945in research payments, 2019–2025

Across 3 payments — averaging $17,648 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Veryan Medical Incorporated$50K
  • Medtronic$3K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$173,161 in reported general payments places this provider in the 95th percentile of 385 vascular surgery providers in Florida.

See all vascular surgery providers in Florida

Medicare billing

Part B allowed, 2024
$1,831,516
Medicare patients
1,436
Services billed
5,338

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Pensacola

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →